It has been recently reported that EZH2 inhibition increases cell apoptosis and reduces cell proliferation in glioma (Wang et al., 2019), and it also potentially prevents macrophage-dependent disease development (Neele and de Winther, 2018). The gene discussed is EZH2; the disease is glioma.